Retail inflation rises to 2.75% in January; MoSPI rolls out new CPI series with 2024 base year

India set to get Bangladesh-style zero-duty access in US for cotton-based textile exports: Piyush Goyal

Manufacturing at the core of India’s $35 trillion economy goal by 2047: Govt

Closing Bell: Sensex falls 558 points, Nifty 50 below 25,900 - Anil Singhvi cites reasons for market decline

Bharat Bandh on February 12: Farmers, unions march nationwide; roads blocked, transport hit in several states

PMO leaves South Block after 78 years as PM Modi shifts office to 'Sewa Teerth'

TCS market cap slips below Rs 10 lakh crore for first time since Dec 2020; ICICI Bank overtakes

Bharat Forge Q3 Results: Net profit at Rs 273 crore, misses estimates; margin shrinks

HAL Q3 FY26 Results: Defence PSU announces 700% interim dividend after 30% jump in net profit - Check record date 

Aye Finance IPO Allotment: Here's how to check status on NSE, BSE, KFin Technologies step-by-step

Anil Singhvi’s Birthday Pick: Why is he bullish on this multibagger stock?

Renowned investor Vijay Kedia holds 10,00,000 equity shares, which translates into a 1.4 per cent stake in Sudarshan Chemical, as per the latest BSE shareholding pattern of the company.&nbsp;

This Vijay Kedia chemical stock declines around 9% intraday on weak Q1 performance – Brokerages say this

The BSE Sensex opened over 175 points lower and Nifty50 started above the 16100-level. While broader markets followed the benchmarks suite as both mid &amp; small-cap down over 0.3 per cent.

Buy, Sell or Hold: What should investors do with Sudarshan Chemical, Bharti Airtel and Hitachi Energy India?

Kedia holds 1,000,000 equity shares, which accounts for 1.4 per cent equity in Sudarshan Chemical, as per the latest BSE shareholding pattern of the company.

Vijay Kedia Stocks: Sudarshan Chemical stock may grow around 24%, opine brokerages; list key triggers here! 

The Indian market ended marginally lower on Wednesday as it snapped a two-day winning streak to close in the red

Buy, Sell or Hold- What should investors do with MRPL, Sudarshan Chemical and Metropolis Healthcare?